TheraKine Ltd.

TheraKine Ltd. is a dynamic ophthalmic specialty pharmaceutical company focused on bringing the innovative power of biologics and biological mechanisms to the treatment of eye diseases. With a commitment to improving vision and preventing blindness, TheraKine is dedicated to developing advanced therapeutic systems that address the common cause of vision loss in serious eye diseases: inflammation.

TheraKine's pipeline of therapies targets inflammation using clinically proven biologic drugs and small molecule inhibitors, delivered through Sustained Release Delivery Systems. These systems are designed to place drugs inside the Blood-Eye Barrier at the source of inflammation, ensuring better outcomes, fewer side effects, and lower costs over several months. TheraKine is headquartered in Agoura Hills, US, and is focused on innovative treatments for ophthalmic conditions.

With a forward-looking approach, TheraKine Ltd. is committed to enhancing the quality of life for patients through cutting-edge research and development. To learn more about how TheraKine is transforming eye care, we invite you to visit their website. Management at TheraKine Ltd. is actively completing additional company details to further showcase their expertise and solutions. We invite the manager to create a customized and exclusive company showcase and product listing on our platform.